Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 1300-1305, March 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brezicka, F.-T.
Right arrow Articles by Lindholm, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brezicka, F.-T.
Right arrow Articles by Lindholm, L.

Immunohistological Detection of Fucosyl-Gm1 Ganglioside in Human Lung Cancer and Normal Tissues with Monoclonal Antibodies1

Fred-Thomas Brezicka2, Sante Olling, Olle Nilsson, Jonas Bergh, Jan Holmgren, Sverre Sörenson, Fridrik Yngvason and Leif Lindholm

Departments of Medical Microbiology [F-T. B., J. H., L. L.] and Pathology [S. O.], University of Göteborg, S-413 46 Göteborg; Pharmacia Canag, S-402 42 Göteborg [O. N.]; Department of Oncology, University of Uppsala, S-751 85 Uppsala [J. B.]; and Department of Pulmonary Medicine, University of Göteborg, S-402 64 Göteborg [S. S., F. Y.], Sweden

With the aid of a highly specific murine monoclonal antibody, F12, an immunofluorescence method was elaborated that allowed sensitive and specific detection of the ganglioside antigen fucosyl-GM1 (IV2FucII3NeuAcGgOse4Cer) in different types of human lung cancer and normal tissues. Nineteen of 21 cases of small cell lung cancer were positive with the F12 immunofluorescence method as compared to 2 of 10 squamous epithelial cell lung cancers and 1 of 5 large cell lung cancer specimens. Specimens of lung adenocarcinoma (8 cases) and bronchial carcinoid (3 cases) were all negative, as were 2 examined cases of neuroblastoma. No fucosyl-GM1 could be detected in normal lung and bronchus. However, in thymus, spleen, and lamina propria of the small intestine sparsely distributed clusters of small round cells were stained as well as intramural ganglionic cells of the small intestine and islet cells of the pancreas. All other normal tissues tested were negative. Results obtained with immunofluorescence closely agreed with immunochemical determination of fucosyl-GM1 in lipid extracts of tissues. Our findings suggest that fucosyl-GM1 is strongly associated with small cell cancer of the lung and demonstrate that this tumor-associated antigen can be detected with high sensitivity and specificity with an immunofluorescence method based on the use of the F12 monoclonal antibody.

1 This study was supported by grants from the Swedish Cancer Research Council; Stena Diagnostics, Ltd., Göteborg, Sweden; the Swedish Technical Research Council; Swedish National Society against Heart and Chest diseases; Åke Wiberg's Foundation; Svenska Läkaresällskapet and the Medical Faculty, Universities of Göteborg and Uppsala, Sweden.

2 To whom requests for reprints should be addressed, at Department of Medical Microbiology, Guldhedsgatan 10, S-413 46 Göteborg, Sweden.

Received 12/ 5/86. Revised 8/ 3/88. Revised 11/ 4/88. Accepted 11/10/88.




This article has been cited by other articles:


Home page
GlycobiologyHome page
N. Tokuda, Q. Zhang, S. Yoshida, S. Kusunoki, T. Urano, K. Furukawa, and K. Furukawa
Genetic mechanisms for the synthesis of fucosyl GM1 in small cell lung cancer cell lines
Glycobiology, October 1, 2006; 16(10): 916 - 925.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. M. Krug, G. Ragupathi, C. Hood, M. G. Kris, V. A. Miller, J. R. Allen, S. J. Keding, S. J. Danishefsky, J. Gomez, L. Tyson, et al.
Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin
Clin. Cancer Res., September 15, 2004; 10(18): 6094 - 6100.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
X. Zhang and F. L. Kiechle
Glycosphingolipids in Health and Disease
Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 3 - 13.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. K.-K. Mong, H.-K. Lee, S. G. Duron, and C.-H. Wong
Reactivity-based one-pot total synthesis of fucose GM1 oligosaccharide: A sialylated antigenic epitope of small-cell lung cancer
PNAS, February 4, 2003; 100(3): 797 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. S. Berenson, R. H. Rasp, J.-T. Gau, J. L. Ryan, and H. C. Yohe
Differences in splenic B-lymphocyte ganglioside expression and accessibility in normal and endotoxin-hyporesponsive mice
J. Leukoc. Biol., June 1, 2001; 69(6): 969 - 976.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. N. Dickler, G. Ragupathi, N. X. Liu, C. Musselli, D. J. Martino, V. A. Miller, M. G. Kris, F.-T. Brezicka, P. O. Livingston, and S. C. Grant
Immunogenicity of a Fucosyl-GM1-Keyhole Limpet Hemocyanin Conjugate Vaccine in Patients with Small Cell Lung Cancer
Clin. Cancer Res., October 1, 1999; 5(10): 2773 - 2779.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.